These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17317952)

  • 21. Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1.
    Balsamo A; Cicognani A; Gennari M; Sippell WG; Menabò S; Baronio F; Riepe FG
    Eur J Endocrinol; 2007 Feb; 156(2):249-56. PubMed ID: 17287415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses to diuretic treatment in gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1.
    Artunc F; Ebrahim A; Siraskar B; Nasir O; Rexhepaj R; Amann K; Friedrich B; Risler T; Lang F
    Kidney Blood Press Res; 2009; 32(2):119-27. PubMed ID: 19401625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients.
    Trochen N; Ganapathipillai S; Ferrari P; Frey BM; Frey FJ
    Nephrol Dial Transplant; 2004 Oct; 19(10):2499-504. PubMed ID: 15304560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.
    Jeong HA; Park YK; Jung YS; Nam MH; Nam HK; Lee KH; Rhie YJ
    Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):230-4. PubMed ID: 26817011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.
    Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel frameshift mutation in NR3C2 leads to decreased expression of mineralocorticoid receptor: a family with renal pseudohypoaldosteronism type 1.
    Kawashima Sonoyama Y; Tajima T; Fujimoto M; Hasegawa A; Miyahara N; Nishimura R; Hashida Y; Hayashi A; Hanaki K; Kanzaki S
    Endocr J; 2017 Jan; 64(1):83-90. PubMed ID: 27725360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.
    Lee SE; Jung YH; Han KH; Lee HK; Kang HG; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2011 Feb; 54(2):90-3. PubMed ID: 21503203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1.
    Ekinci Z; Aytac MB; Cheong HI
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1197-200. PubMed ID: 23813355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathogenesis of renal pseudohypoaldosteronism type 1.
    Riepe FG
    Expert Rev Endocrinol Metab; 2007 May; 2(3):407-419. PubMed ID: 30743803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.
    Chang SS; Grunder S; Hanukoglu A; Rösler A; Mathew PM; Hanukoglu I; Schild L; Lu Y; Shimkets RA; Nelson-Williams C; Rossier BC; Lifton RP
    Nat Genet; 1996 Mar; 12(3):248-53. PubMed ID: 8589714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
    Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
    Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism.
    Adachi M; Asakura Y; Muroya K; Tajima T; Fujieda K; Kuribayashi E; Uchida S
    Clin Exp Nephrol; 2010 Jun; 14(3):228-32. PubMed ID: 20376516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome.
    Artunc F; Nasir O; Amann K; Boini KM; Häring HU; Risler T; Lang F
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1624-34. PubMed ID: 18768591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene.
    Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ
    J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
    Arai K; Shibasaki T
    Nihon Rinsho; 2002 Feb; 60(2):361-6. PubMed ID: 11857927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
    Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
    J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.
    Dirlewanger M; Huser D; Zennaro MC; Girardin E; Schild L; Schwitzgebel VM
    Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E467-73. PubMed ID: 21653223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.